Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients.

We evaluated in maintenance hemodialysis patients the potassium lowering effects of intravenous insulin with glucose, nebulized albuterol, and a regimen combining both modalities. There was a similar decrease in plasma potassium following either insulin with glucose (0.65 +/- 0.

Nebulized albuterol for acute hyperkalemia in patients on hemodialysis.

Study Objective: To determine the efficacy and safety of nebulized albuterol in the acute treatment of hyperkalemia in patients on chronic hemodialysis.

Design: Prospective, double-blind, and placebo-controlled study.

Setting: Outpatient hemodialysis clinic at a university medical center.